| 注册
首页|期刊导航|北京中医药大学学报|红花水提物及羟基红花黄色素A对原发性痛经寒凝血瘀证大鼠的作用及机制研究

红花水提物及羟基红花黄色素A对原发性痛经寒凝血瘀证大鼠的作用及机制研究

王然 孙颖 焦伯阳 李春 李军 屠鹏飞

北京中医药大学学报2024,Vol.47Issue(10):1397-1407,11.
北京中医药大学学报2024,Vol.47Issue(10):1397-1407,11.DOI:10.3969/j.issn.1006-2157.2024.10.010

红花水提物及羟基红花黄色素A对原发性痛经寒凝血瘀证大鼠的作用及机制研究

Study on effect and mechanisms of Carthami Flos water extract and hydroxysafflower yellow A on primary dysmenorrhea rats with cold coagulation and blood stasis

王然 1孙颖 2焦伯阳 2李春 3李军 1屠鹏飞4

作者信息

  • 1. 北京中医药大学中药学院 北京 102488||北京中医药大学北京中医药研究院中药现代研究中心
  • 2. 北京中医药大学中医学院
  • 3. 北京中医药大学北京中医药研究院中药现代研究中心
  • 4. 北京大学药学院天然药物及仿生药物国家重点实验室
  • 折叠

摘要

Abstract

Objective To explore the pharmacological effects and regulatory mechanisms of Carthami Flos water extract and its main constituent,hydroxysafflower yellow A(HSYA),on primary dysmenorrhea rats with cold coagulation and blood stasis.Methods Forty-two female specific pathogen-free grade rats aged 6-8 weeks were divided into blank,model,HSYA(0.01 g/kg),ibuprofen(0.04 g/kg),and low(0.06 g/kg),medium(0.20 g/kg),and high(0.40 g/kg)Carthami Flos water extract dose groups using the random number table method,with six rats per group.A rat model was established using ice water bath stimulation combined with estradiol benzoate and oxytocin.Continuous gavage was administered for 6 days from the seventh day of modeling.After the intervention,the writhing reaction test was conducted.The rats,uteri,and ovaries were weighed to calculate the organ index.An enzyme-linked immunosorbent assay and radioimmunoassay were used to detect the prostaglandin E2(PGE2)and prostaglandin F2α(PGF2α)contents in the uterus,thromboxane B2(TXB2)and 6-keto-prostaglondin F1α(6-keto-PGF1α)in plasma,and estradiol(E2)in the serum.Hematoxylin and eosin staining were used to detect the pathological changes in uterine tissue.Immunohistochemistry was used to determine cyclooxygenase-2(COX-2)expression in uterine tissue,whereas immunofluorescence was used to measure follicle-stimulating hormone receptor(FSH-R)expression in ovarian tissue.Western blotting was used to detect gonadotropin-releasing hormone receptor(GnRH-R)and FSH-R expression in uterine tissue.Results Compared with the blank group,the rats in the model group exhibited an increase in uterine and ovarian indices and increased PGE2 and PGF2α in the uterus.TXB2 in the plasma and E2 in the serum were also evaluated.Additionally,6-keto-PGF1α decreased,and COX-2,GnRH-R,and FSH-R expression in the uterus and FSH-R expression in the ovaries also increased(P<0.05).The morphology of the uterine tissue was disordered.Compared with the model group,the low Carthami Flos water extract dose group showed a decrease in uterine index(P<0.05).In the medium and high Carthami Flos water extract dose groups,the writhing response decreased,as did the uterine and ovarian indicesand PGE2 and TXB2 contents.The 6-keto-PGF1α content increased,whereas the GnRH-R protein expression in the uterus decreased(P<0.05).The high Carthami Flos water extract dose group also showed a decrease in PGF2α and FSH-R protein expression in the uterus(P<0.05).In the HSYA group,the writhing response decreased,the uterine and ovarian indices decreased,the PGE2,PGF2α,and TXB2 contents decreased,and GnRH-R and FSH-R protein expression decreased in the uterus(P<0.05).The serum E2 levels of the groups that received Carthami Flos water extract at various doses and those of the HSYA group were reduced,and the uterine morphology was improved.COX-2 expression in the uterus and FSH-R protein expression in the ovaries were also reduced(P<0.05).Conclusion Carthami Flos water extract and HSYA can improve the pathological state of primary dysmenorrhea rats with cold coagulation and blood stasis.Its mechanism may be related to regulating the hypothalamic-pituitary-ovary axis.

关键词

红花/羟基红花黄色素A/原发性痛经/寒凝血瘀证/下丘脑-垂体-卵巢轴/大鼠

Key words

Carthami Flos/hydroxysafflower yellow A/primary dysmenorrhea/cold coagulation and blood stasis/hypothalamic-pituitary-ovary axis/rats

分类

医药卫生

引用本文复制引用

王然,孙颖,焦伯阳,李春,李军,屠鹏飞..红花水提物及羟基红花黄色素A对原发性痛经寒凝血瘀证大鼠的作用及机制研究[J].北京中医药大学学报,2024,47(10):1397-1407,11.

基金项目

国家重点研发计划项目(No.2022YFC3501602) National Key R&D Program of China(No.2022YFC3501602) (No.2022YFC3501602)

北京中医药大学学报

OA北大核心CSTPCD

1006-2157

访问量0
|
下载量0
段落导航相关论文